Cardiovascular Diseases

Empagliflozin and Cardiac Remodelling in People Without Diabetes

Diabetes Remote Intervention to improVe Use of Evidence-based Medications

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk

A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI

Pilot Study of Using Copeptin to Predict Response to Tolvaptan

Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

PreFER Managed Ventricular Pacing (MVP) For Elective Replacement

Vytorin on Carotid Intima-media Thickness and Overall Rigidity

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction

Iron in Patients With Cardiovascular Disease

A Study of Evacetrapib in High-Risk Vascular Disease

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Niacin Plus Statin to Prevent Vascular Events

Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest

Raloxifene Use for The Heart

Calcium for Pre-Eclampsia Prevention (CPEP)

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

Thromboxane Receptor Antagonist to Improve Endothelial Function

Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

Red Blood Cell ATP Release and Vascular Function in Humans

Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System

A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Promoting Healthy Lifestyles Among Firefighters

A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis

Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

An ADME Study of [14C]AZD0780 in Healthy Male Subjects

Treating Congestive HF With hiPSC-CMs Through Endocardial Injection

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers